Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Dept. |
RCV001726609 | SCV001961002 | likely pathogenic | 46,XY sex reversal 3 | criteria provided, single submitter | clinical testing | ||
Gene |
RCV004699442 | SCV005201389 | pathogenic | not provided | 2024-02-07 | criteria provided, single submitter | clinical testing | Published in vitro functional studies demonstrate decreased DNA binding and transactivation activity (PMID: 17656604); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 36617173, 26362256, Gaisl12019[Poster], 35729303, 36793102, 24434652, 17656604, 30103258, 33202802, 17694559) |
Center for Reproductive Medicine, |
RCV001661771 | SCV001877135 | likely pathogenic | Genetic non-acquired premature ovarian failure | 2019-10-01 | no assertion criteria provided | research |